Intra-Cellular Therapies
ITCI
#1293
Rank
NZ$24.30 B
Marketcap
$228.59
Share price
-0.08%
Change (1 day)
116.11%
Change (1 year)

EPS for Intra-Cellular Therapies (ITCI)

EPS in 2023 (TTM): -$2.60

According to Intra-Cellular Therapies's latest financial reports the company's current EPS (TTM) is -$2.80. In 2022 the company made an earnings per share (EPS) of -$4.74 an increase over its 2021 EPS that were of -$6.10.

EPS history for Intra-Cellular Therapies from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.60-45.09%
2022-$4.74-22.29%
2021-$6.108.02%
2020-$5.6420.9%
2019-$4.67-5.63%
2018-$4.9533.96%
2017-$3.69-21.19%
2016-$4.68-7.56%
2015-$5.07174.53%
2014-$1.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.44-84.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-$17.42 521.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.73 32.92%๐Ÿ‡บ๐Ÿ‡ธ USA